Blue Jay Capital Management

Latest statistics and disclosures from Blue Jay Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Blue Jay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Blue Jay Capital Management

Blue Jay Capital Management holds 20 positions in its portfolio as reported in the June 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Tesaro 6.4 $9.4M -20% 68k 139.86
 View chart
Clovis Oncology 6.3 $9.3M -33% 99k 93.63
 View chart
Incyte Corporation (INCY) 6.2 $9.1M +3% 72k 125.91
 View chart
Ironwood Pharmaceuticals (IRWD) 6.0 $8.9M -30% 470k 18.88
 View chart
Wright Medical Group Nv 6.0 $8.8M +4% 320k 27.49
 View chart
BioMarin Pharmaceutical (BMRN) 5.8 $8.6M -10% 95k 90.82
 View chart
Pra Health Sciences 5.5 $8.0M -23% 107k 75.01
 View chart
Edwards Lifesciences (EW) 5.4 $8.0M -25% 67k 118.25
 View chart
Abiomed 5.4 $7.9M -26% 55k 143.30
 View chart
Nevro (NVRO) 5.3 $7.8M +5% 105k 74.43
 View chart
Qiagen Nv (QGEN) 5.0 $7.3M NEW 218k 33.53
 View chart
Smith & Nephew (SNN) 4.8 $7.0M NEW 200k 34.85
 View chart
Portola Pharmaceuticals 4.6 $6.7M NEW 120k 56.17
 View chart
Neurocrine Biosciences (NBIX) 4.5 $6.7M NEW 145k 46.00
 View chart
Brookdale Senior Living (BKD) 4.5 $6.6M NEW 450k 14.71
 View chart
Icon (ICLR) 4.2 $6.2M NEW 63k 97.79
 View chart
Vertex Pharmaceuticals Incorporated (VRTX) 4.1 $6.0M -42% 46k 128.87
 View chart
Align Technology (ALGN) 3.5 $5.1M NEW 34k 150.13
 View chart
Illumina (ILMN) 3.2 $4.8M NEW 28k 173.53
 View chart
Intuitive Surgical (ISRG) 3.2 $4.7M NEW 5.0k 935.40
 View chart

Past Filings by Blue Jay Capital Management

SEC 13F filings are viewable for Blue Jay Capital Management going back to 2014